Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.

Chengdu Innodabo Pharmaceutical Technology Co., Ltd., established on 2007-12-04, Business scope includes chemicals,Technology development and transfer of biopharmaceuticals;Chemical product sales(Free of Hazardous Chemicals);Import and export,Technology Import and Export(law,Except where prohibited by administrative regulations;law,Operations can only be carried out after obtaining a license restricted by administrative regulations).

Hunan Eurasia Pharmaceutical Co., Ltd., established on 2007-11-22, Business scope includes chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals)manufacturing,Sales;Manufacture of chemical raw materials;Production of disinfection products;Class I medical device,Class II medical device,Class III Medical Devices,Wholesale of chemical raw materials;Chemical Engineering Research Services;Chemical Products,Biological product,drug development;disinfectant,Sanitation products,Drug inspection and testing equipment sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

MSN Laboratories Pvt Ltd. is an Indian private company with domestic subsidiaries, that engages in research and development of pharmaceuticals.

Shanghai Tianci International Pharmaceutical Co., Ltd., established on 2013-10-16, Business scope includes biotechnology,Technology development in the field of medical technology,technical consulting,technology transfer,Technical Services,medicine,Biological product,R&D of medical devices,pharmaceutical production,Pharmaceutical commissioned production(For details, see Drug Registration Approval Document for Drug Marketing Authorization Holders),business inquiries,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

TyrNovo is developing NT219, a small molecule originally developed by Dr. Hadas Reuveni and Prof. Alexander Levitzki at the Hebrew University, and exclusively licensed from Yissum, the Hebrew University Research Development Company. TyrNovo demonstrated the potential of NT219 to overcome resistance to multiple anti-cancer drugs, by using the Patient-Derived Xenograft (PDX) models, in collaboration with Prof. Izhak Haviv from the Bar-Ilan University and Prof. M. Stemmer from Clalit HMO.

Ruiyang Pharmaceutical Co., Ltd., established on 1998-03-20, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug retail;Drug Wholesale;Drug import and export;road freight transport(Does not contain dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of medical packaging materials;Sales of packaging materials and products;Non-residential real estate leases;Import and export;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Yuexing Pharmaceutical Co., Ltd., established on 2002-05-30, Business range includes tablet(Including external use,Contains anti-tumor),hard capsule,Granules,small volume injection(non-terminal sterilized,terminal sterilization),large volume injection,oral solution production;Technology research and development in the field of pharmaceutical production and technology,technical consulting,technology transfer,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China.

Hunan Nucien Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It offers antibiotics, antipyretic and analgesic, and drugs for cardiovascular and cerebrovascular diseases in the form of injections, tablets and capsules. Its products include simvastatin dispersible tablets, benazepol hydrochlorothiazide tablets, cefaclor capsules, ciprofloxacin lactate sodium chloride injections, and compound ibuprofen tablets. The company was founded on December 27, 2006 and is headquartered in Changsha, China.

Yingkerui (Tianjin) Innovative Pharmaceutical Research Co., Ltd., established on 2011-08-24, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Specialty Chemical Products(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Drug Wholesale;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Aurisco Pharma is a manufacturer of APIs, FDFs, and CRDMOs of oligonucleotide APIs. It has become a partner of many pharmaceutical firms and has a role in the fields of complex synthesis, synthetic biology, oligonucleotide synthesis, photochemistry, and other disciplines.

Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd., established on 2011-04-11, The business scope includes Chinese and Western medicines,Development of pharmaceutical raw materials,to develop;API,Antitumor raw materials,Sterile API,Chemical raw materials for pharmaceutical production,Production of excipients and intermediates,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Part of Sichuan Kelun Pharmaceutical Co., Ltd., Sichuan Kelun Pharmacy Institute Co., Ltd. is a company headquartered in Chengdu, China. The firm manufactures medicines. It was founded in 1998.

Jiangsu Qianyuan Construction Co., Ltd., established on 2011-04-13, Business scope includes construction works,Municipal public works,Road construction,Water Resources and Hydropower Engineering,General contracting of electric power engineering construction;Building decoration project,Building Curtain Wall Engineering,Ancient Architecture,City and road lighting engineering,Steel structure engineering,Fire facilities engineering,Mechanical and electrical equipment installation engineering,Electronics and Intelligent Engineering,Design and construction of sports facilities;Foundation and Foundation Engineering,Earthwork,Ready Mixed Concrete Works,bridge engineering,Chemical and petroleum equipment pipeline installation project,Communication Engineering,Environmental Engineering,Waterproof, anti-corrosion and thermal insulation engineering,River and lake improvement project,Formwork and scaffolding installation works,Special professional engineering construction;Metal door and window installation;Greenhouse production and installation;Planting and sales of horticultural crops;the garden,landscape,Greening Engineering Design,construction,conservation;Sales of building materials;Construction labor subcontracting;design,make,release signage,neon lights,LEDdisplay screen,light box,Move-in Advertisement.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:building demolition work(Except for blasting operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on December 14, 1995 and is headquartered in Linyi, China.